DGEN OTC
Deltagen Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -0.0%
5Y: -0.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.0001-0.0001
Volume442,968
Avg Volume403,665
Beta2.49
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEORobert J. Driscoll
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date2000-08-03
Websited-gen.co.il
1900 South Norfolk Street
San Mateo, CA 94403
US
San Mateo, CA 94403
US
650-345-7601
About Deltagen Inc.
Deltagen Inc. provides drug discovery tools and services to the biopharmaceutical industry. The company offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, as well as small-molecule and secreted protein drug targets. It also provides target validation data in the areas of immunology and metabolic diseases. The company was incorporated in 1999 and is headquartered in San Mateo, California.
Latest News
No recent news
Recent Insider Trades
No insider trades found